35
https://pubmed.ncbi.nlm.nih.gov/38093367
The study finds that USP13 gene amplification drives lung squamous cell carcinoma by altering lineage-determining factors and upregulating squamous programs in both murine and human lung cancer cells, suggesting USP13 as a potential therapeutic target for LUSC.
